In addition, carriers of severe GBA1 mutations (i.e. IVS 2 + 1, 84GG, D409H) exhibit a substantially decreased age of onset of PD compared with carriers with milder mutations associated higher residual enzyme activity (i.e. N370S) (17). The gene discussed is GBA1; the disease is Parkinson disease.